Patients
New hope for ovarian cancer, with Alexander Schneider
Alexander Schneider, CEO of CureLab Oncology, shares how his company’s drug candidate for platinum-resistant ovarian cancer is named after his wife.
Sales & Marketing
A fast start to 2026 signals continued investor confidence i...
Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.
Patients
Patient centricity: How pharma can move beyond the buzzwords
One important way that pharma companies can deliver true patient advocacy is by bringing cross-functional experience to the table.
Sales & Marketing
Changing Faces: Agency and consultancy, January 2026
The pharmaceutical services sector saw a flurry of new executive hires last month, spanning agencies, consultancies, investment firms & a few others.
R&D
Sponsored
Best practices in cardiometabolic trial design: Planning and...
Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
